The risk of acute myocardial infarction with etodolac is not increased compared to naproxen: A historical cohort analysis of a generic COX-2 selective inhibitor

John J. Warner, Rick A. Weideman, Kevin C. Kelly, Emmanouil S. Brilakis, Subhash Banerjee, Francesca Cunningham, William V. Harford, Salahuddin Kazi, Bertis B. Little, Byron Cryer

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint Dive into the research topics of 'The risk of acute myocardial infarction with etodolac is not increased compared to naproxen: A historical cohort analysis of a generic COX-2 selective inhibitor'. Together they form a unique fingerprint.

Medicine & Life Sciences